3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Head & Neck
1
Conditions
Breast Neoplasms
1
Breast Cancer Patient
1
Agnosia
1
Interventions
Paclitaxel
161
Fulvestrant
155
Trastuzumab
152
pembrolizumab
144
Letrozole
136
Carboplatin
118
pertuzumab
104
Cyclophosphamide
102
Capecitabine
102
Specimen Handling
101
Anastrozole
90
palbociclib
85
abemaciclib
81
Magnetic Resonance Spectroscopy
81
exemestane
76
Docetaxel
76
Tamoxifen
75
ribociclib
73
trastuzumab deruxtecan
69
Radiotherapy
61
Biopsy
59
Surveys and Questionnaires
56
Gemcitabine
52
130-nm albumin-bound paclitaxel
52
sacituzumab govitecan
50
olaparib
50
Standard of Care
49
Blood Specimen Collection
49
Taxes
47
Doxorubicin
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Capsaicin
×
Breast
×
1 year
×
Clear all
NCT03794388
2026-05-05
CAPTRANE
Institut Cancerologie de l'Ouest
Phase 3
Completed
140 enrolled
6 charts
NCT06807164
2026-03-27
SerCaBot
Centre Oscar Lambret
Phase 2
Recruiting
123 enrolled